Johnson & Johnson has reached a deal to acquire Shockwave Medical for around $13.1 billion, expanding its position in medical devices used to treat heart disease.
J&J has agreed to pay $335 per share in cash for Santa Clara, California-based Shockwave, which specialises in intravascular lithotripsy (IVL) technology for the treatment of calcified blood vessels in coronary artery disease (CAD) and peripheral artery disease (PAD).
